There has been a growing body of supporting evidence in the translational research field showing the role genomic- and proteomic-based platforms in enabling more informed and potentially effective therapeutic strategies in clinical development and when appropriate transitioning to diagnostic applications. Hear from Labcorp Drug Development Sr.
Looking to better assess treatment benefit, drug developers for rare diseases are eager to incorporate remote monitoring solutions to complement the "snapshot" data collected at clinical visits and to collect richer data on how patients function at home.
The Official Launch of the Labcorp Singapore Bioanalytical Services and Central Laboratory, is a reaffirmation of our commitment to continue our efforts in providing bioanalytical solutions to all our clients across the fast-growing APAC region by driving strategic partnerships, quality and operational excellence.
In this video, learn about the central pharmacy management and in-human infusion services to reduce travel and investigator site staff burden of the trial.
The development pathway for engineered cell-based therapies faces several unique challenges, particularly with safety assessment and medical monitoring.
